Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GL701 in Women with Active SLE
NCT00004662Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Mar 1996
- Modality
- Allosteric Modulators
01
Overview
Phase 3, randomised, double-blind trial of dehydroepiandrosterone in systemic lupus erythematosus (SLE) (2 arms), sponsored by National Center for Research Resources. Primary endpoint: Responder Rate based on SLEDAI, SLAM, Krupp Fatigue Severity Score, and Patient Global Assessment at 52 weeks. Started Mar 1996; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00004662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004662.